Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03435770	Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms	unknown	N/A	10	Singapore General HospitalOTHER	1	Feb 20, 2018	clinicaltrials
NCT02607826	Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors	unknown	N/A	298	University Hospital TuebingenOTHER	0	Oct 28, 2016	clinicaltrials